Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMPACT, a Supervised Rehabilitation Program for Spastic Ataxias: A Rater-blinded, Randomized Controlled Trial

NCT06261424 is registered in ClinicalTrials.gov with Laval University as lead sponsor.

NCT NCT06261424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06261424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMPACT, a Supervised Rehabilitation Program for Spastic Ataxias: A Rater-blinded, Randomized Controlled Trial
Lead sponsor
Laval University
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2024
Completion date
March 31, 2027
Enrollment
84 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal recessive spastic ataxia of charlevoix-saguenay, spastic paraplegia 7